Inside Logistics

DHL adds 13 locations throughout the Americas to its life sciences Thermonet network


July 2, 2014
by

TORONTO, Ont.–DHL Global Forwarding is adding to the company’s worldwide Thermonet network of Certified Life Sciences Stations in the Americas. Thermonet locations added to the network include: Buenos Aires, Argentina; Santiago,

Chile; Bogota, Colombia; Toronto, Canada; Rio de Janeiro and Sao Paulo, Brazil; Mexico City, Mexico; Panama City, Panama; San Juan, Puerto Rico; Caracas and Valencia, Venezuela; and Boston and New York in the U.S. The facilities offer 35° to 46° F (+2° to +8° C) cold storage space to serve DHL’s global customer base in the Life Sciences & Healthcare sector with temperature-controlled air freight shipment needs.

“With the expansion of our Thermonet certified facilities this means consignors and consignees have access across the Americas to a reliable end-to-end cold chain,” said David Bang, CEO of LifeConEx, a part of DHL Global Forwarding. “These DHL Global Forwarding facilities include highly trained personnel capable of handling any type of temperature sensitive pharmaceutical or biomedical items.”

DHL plans to integrate more than 65 stations across the globe by the end of 2014 and 80 Deutsche Post DHL. The Mail & Logistics Group. by the end of 2015. All the facilities are audited against globally defined Good Distribution

Practices (GDP) to ensure conformity across the network, said the company. Several of the facilities provide

temperature monitoring, dry ice replenishing, active and non-active container handling to ensure product quality at all times. For the upcoming months, DHL plans to further expand some of the station’s capabilities with additional storage space.

In recent years, temperature controlled products for the pharmaceutical industry have gained significant importance. The driving force is biotechnology products, which generally must be kept within a strict temperature range during transportation. The worldwide sales volume of this product category tripled from USD $56 billion in 2004 to an estimated USD $167 billion in 2013.1 Further growth is expected in the future, said a release.